This page specifies the COVID-19 logic implemented by ICE for recommendations before September 12, 2023.
For COVID-19 logic for recommendations as of September 12, 2023 onwards, see COVID-19 Vaccine Group - September 2023 Onwards.
Two Shot Same Day Exception Rules for COVID-19
For COVID-19 shots administered:
General rules are not series-specific; general rules apply to the entire vaccine group.
Rules for Recommending at the CVX Code vs. Vaccine Group Level
Series Completion Special Rule
Rules for an Additional Dose1
Rules for Booster Dose2Any of the FDA-Approved COVID-19 vaccines (except CVX 218) can be used for booster vaccination, regardless of the vaccine product used for primary vaccination. When a heterologous or “mix and match” booster dose is administered, the eligible population and dosing intervals are those of the vaccine used for primary vaccination. Recommendation Rules for Booster Dose or Requirement for a Dose with a Bivalent Vaccine
Evaluation Rules for Booster Dose
Rules for Evaluation of Extra Shots After Additional Dose1 and/or Booster Doses and/or Needed Bivalent Dose2
|
Notes
|
CVX Code | Name | Absolute Minimum Age | Absolute Maximum Age | Counts towards U.S. Vaccination |
---|---|---|---|---|
207 | Moderna COVID-19 Vaccine | 0 days | Yes | |
208 | Pfizer COVID-19 Vaccine | 0 days | Yes | |
210 | AstraZeneca COVID-19 Vaccine | 0 days | Yes | |
211 | Novavax COVID-19 Vaccine | 0 days | Yes | |
212 | Janssen COVID-19 Vaccine | 0 days | Yes | |
213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | 0 days | Yes | |
217 | Pfizer COVID-19 Vaccine (>= 12 years) | 0 days | Yes | |
218 | Pfizer COVID-19 Vaccine | 0 days | 18 years - 1 day | Yes |
219 | Pfizer COVID-19 Vaccine | 0 days | 6 years - 1 day | Yes |
221 | Moderna COVID-19 Vaccine | 0 days | Yes | |
227 | Moderna COVID-19 Vaccine (Inactive) | 0 days | 13 years - 1 day | Yes |
228 | Moderna COVID-19 Vaccine | 0 days | 7 years - 1 day | Yes |
229 | Moderna COVID-19 Vaccine, Bivalent | 0 days | Yes | |
230 | Moderna, COVID-19 Vaccine, Bivalent Booster | 0 days | 7 years - 1 day | Yes |
300 | Pfizer COVID-19 Vaccine, Bivalent | 0 days | Yes | |
301 | Pfizer COVID-19 Vaccine, Bivalent | 0 days | 12 years - 1 day | Yes |
302 | Pfizer, COVID-19 Vaccine, Bivalent | 0 days | 6 years - 1 day | |
500 | COVID-19 Non-US Vaccine, Product Unknown | No | ||
501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | No | ||
502 | COVID-19 IV Non-US Vaccine (COVAXIN) | 0 days | Yes | |
503 | COVID-19 LAV Non-US Vaccine (COVIVAC) | No | ||
504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | No | ||
505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) | No | ||
506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) | No | ||
507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbology Chinese academy of Sciences) | No | ||
508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | No | ||
509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) | No | ||
510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | 0 days | Yes | |
511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | 0 days | Yes | |
512 | COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | 18 years - 4 days | Yes | |
513 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | No | ||
514 | COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | No | ||
515 | COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | No | ||
516 | COVID-19 Inactivated Non-US Vaccine (Minhai Biotechnology Co, KCONVAC) | No | ||
517 | COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | No | ||
518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | No | ||
519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | 0 days | Yes | |
520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | 0 days | Yes | |
521 | COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK | No |
No combination vaccines exist, at this time, that include COVID-19 and count toward completion of the Pfizer COVID-19 2-dose series.
CVX Code Specific RulesCVX Code Absolute Minimum Age
CVX Code Absolute Maximum Age
Rule for CVX 218, CVX 219, CVX 227, CVX 228, CVX 229, CVX 230, CVX 301, CVX 302
Rule for Bivalent Vaccines (CVX 229, CVX 230, CVX 300, CVX 301, CVX 301, CVX 519, CVX 520)
Rule for CVX 213
Rules for COVID-19 Vaccines Not Authorized by FDA2The following set of rules apply to 1) COVID-19 Vaccines Not Authorized by FDA, but Authorized by WHO and, 2) COVID-19 Vaccines Not Authorized by FDA or WHO, but is an Active COVID-19 Vaccine Candidate as part of a U.S.-based Clinical Trial of a COVID-19 Vaccine.
|
Notes
|
Series Name
Series Selection RulesThere are five series for this vaccine group: Pfizer COVID-19 Series, Moderna COVID-19 Series, Mixed Product COVID-19 Series, Janssen COVID-19 Series, and Novavax COVID-19 Series. The rules for determining which series applies are:
|
The Pfizer COVID-19 Series is complete after 2 or 3 doses, depending on age (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age | Routine Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
2 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
3 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Pfizer COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise, 17 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days |
N/A |
Dose 2 to 3 | Pfizer COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
The Moderna COVID-19 series is complete after 2 doses (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228, 229 | N/A |
2 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228, 229 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Moderna COVID-19 | 0 days if dose 2 administered < 10/25/2021 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 6 years of age Otherwise, 24 days if dose 2 administered >= 10/25/2021 | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 6 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 administered >= 6 years of age Otherwise, 28 days | N/A |
Series Special Rules
Vaccine to Recommend
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
The Mixed Product COVID-19 Series is complete after 2 or 3 doses, depending on age (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
2 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
3 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Mixed Product COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise:
| 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | N/A |
Dose 2 to 3 | Mixed Product COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 211 (Novavax COVID-19 vaccine)
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
The Janssen COVID-19 Series is complete after 1 dose.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Janssen COVID-19 Series | 0 days | 18 years | 18 years | N/A | 212 | N/A |
Series Special Rules
|
The Novavax COVID-19 Series is complete after 2 doses (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Novavax COVID-19 Series | 12 years - 4 days | 12 years | 12 years | N/A | 211 | |
2 | Novavax COVID-19 Series | 12 years - 4 days | 12 years | 12 years | N/A | 211 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Novavax COVID-19 Series | 17 days | 21 days | 21 days | 8 weeks |